Robert Stowe

1.1k total citations
19 papers, 579 citations indexed

About

Robert Stowe is a scholar working on Genetics, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Robert Stowe has authored 19 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Molecular Biology and 5 papers in Cognitive Neuroscience. Recurrent topics in Robert Stowe's work include Genomic variations and chromosomal abnormalities (5 papers), Genetics and Neurodevelopmental Disorders (4 papers) and Schizophrenia research and treatment (4 papers). Robert Stowe is often cited by papers focused on Genomic variations and chromosomal abnormalities (5 papers), Genetics and Neurodevelopmental Disorders (4 papers) and Schizophrenia research and treatment (4 papers). Robert Stowe collaborates with scholars based in Canada, United States and Australia. Robert Stowe's co-authors include Bruce H. Price, M.‐Marsel Mesulam, Kirk R. Daffner, Irene Litvan, William E. Klunk, Steven T. DeKosky, Daniel Kaufer, Oscar L. López, James T. Becker and Philip E. Putnam and has published in prestigious journals such as American Journal of Psychiatry, Brain and Neurology.

In The Last Decade

Robert Stowe

18 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Stowe Canada 9 188 143 119 117 71 19 579
Jon‐Kar Zubieta United States 13 152 0.8× 158 1.1× 63 0.5× 90 0.8× 55 0.8× 14 673
Shenxun Shi China 16 122 0.6× 152 1.1× 47 0.4× 66 0.6× 104 1.5× 43 688
Eilis Boudreau United States 18 198 1.1× 197 1.4× 70 0.6× 99 0.8× 114 1.6× 36 797
Jordi Gascón‐Bayarri Spain 17 403 2.1× 215 1.5× 159 1.3× 127 1.1× 63 0.9× 43 789
Rachel Galioto United States 13 187 1.0× 82 0.6× 88 0.7× 71 0.6× 43 0.6× 38 480
Joana Fernandes Portugal 10 128 0.7× 121 0.8× 123 1.0× 121 1.0× 34 0.5× 33 592
Guilherme Riccioppo Rodrigues Brazil 14 111 0.6× 69 0.5× 215 1.8× 77 0.7× 37 0.5× 29 487
Maria Pąchalska Poland 12 167 0.9× 163 1.1× 64 0.5× 58 0.5× 67 0.9× 107 612
Pei‐Shen Ho Taiwan 15 172 0.9× 70 0.5× 53 0.4× 45 0.4× 66 0.9× 38 584
Ching‐Jui Chang Taiwan 16 426 2.3× 171 1.2× 98 0.8× 48 0.4× 157 2.2× 26 877

Countries citing papers authored by Robert Stowe

Since Specialization
Citations

This map shows the geographic impact of Robert Stowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Stowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Stowe more than expected).

Fields of papers citing papers by Robert Stowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Stowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Stowe. The network helps show where Robert Stowe may publish in the future.

Co-authorship network of co-authors of Robert Stowe

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Stowe. A scholar is included among the top collaborators of Robert Stowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Stowe. Robert Stowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Polasek, Thomas M., Chad Bousman, Amin Rostami‐Hodjegan, et al.. (2024). Virtual twins for model‐informed precision dosing of clozapine in patients with treatment‐resistant schizophrenia. CPT Pharmacometrics & Systems Pharmacology. 13(3). 424–436. 5 indexed citations
2.
Narang, Ankita, Paul Lacaze, Kathlyn J. Ronaldson, et al.. (2022). Whole-genome sequencing analysis of clozapine-induced myocarditis. The Pharmacogenomics Journal. 22(3). 173–179. 3 indexed citations
3.
Torres, Ivan J., et al.. (2022). Progressive neurocognitive decline in schizophrenia: A diagnostic dilemma for clinicians. Schizophrenia Research. 241. 59–62. 1 indexed citations
4.
Leonova, Olga, Mahesh Menon, Ric M. Procyshyn, et al.. (2022). Subjective cognitive functioning, depressive symptoms, and objective cognitive functioning in people with treatment-resistant psychosis. Cognitive Neuropsychiatry. 27(6). 411–429.
5.
6.
Yasin, Heba, Robert Stowe, Chi Kin Wong, Puthen V. Jithesh, & Farah Zahir. (2020). First Whole Transcriptome RNAseq on CHD8 Haploinsufficient Patient and Meta-Analyses Across Cellular Models Uncovers Likely Key Pathophysiological Target Genes. Cureus. 12(11). e11571–e11571. 2 indexed citations
7.
Horváth, Gabriella, Robert Stowe, Carlos R. Ferreira, & Nenad Blau. (2020). Clinical and biochemical footprints of inherited metabolic diseases. III. Psychiatric presentations. Molecular Genetics and Metabolism. 130(1). 1–6. 18 indexed citations
8.
Yasin, Heba, William T. Gibson, Sylvie Langlois, et al.. (2019). A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8. Journal of Human Genetics. 64(4). 271–280. 25 indexed citations
9.
Farrell, Martilias S., James J. Crowley, Gabriel Lázaro‐Muñoz, et al.. (2019). THE GENOMICS OF HIGHLY TREATMENT RESISTANT SCHIZOPHRENIA. European Neuropsychopharmacology. 29. S1006–S1007. 1 indexed citations
10.
Menon, Mahesh, Prescilla Carrion, Olga Leonova, et al.. (2019). Preliminary examination of the validity of the NIH toolbox cognition battery in treatment-resistant psychosis. The Clinical Neuropsychologist. 34(5). 981–1003. 5 indexed citations
11.
Farrell, Martilias S., James J. Crowley, Gabriel Lázaro‐Muñoz, et al.. (2018). Developmental Delay, Treatment-Resistant Psychosis, and Early-Onset Dementia in a Man With 22q11 Deletion Syndrome and Huntington’s Disease. American Journal of Psychiatry. 175(5). 400–407. 8 indexed citations
12.
Horváth, Gabriella, et al.. (2017). Improved strength on 5-hydroxytryptophan and carbidopa in spinal cord atrophy. Journal of the Neurological Sciences. 378. 59–62. 5 indexed citations
13.
Iaria, Giuseppe, Christopher J. Fox, Michael Scheel, Robert Stowe, & Jason J.S. Barton. (2009). A case of persistent visual hallucinations of faces following LSD abuse: A functional Magnetic Resonance Imaging study. Neurocase. 16(2). 106–118. 10 indexed citations
14.
Shimozaki, Steven S., Alan Kingstone, Bettina Olk, Robert Stowe, & Miguel P. Eckstein. (2006). Classification images of two right hemisphere patients: A window into the attentional mechanisms of spatial neglect. Brain Research. 1080(1). 26–52. 4 indexed citations
15.
López, Oscar L., Irene Litvan, Robert Stowe, et al.. (1999). Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology. 53(6). 1292–1292. 181 indexed citations
16.
Campo, John V., et al.. (1998). Psychosis as a presentation of physical disease in adolescence: a case of Niemann–Pick disease, type C. Developmental Medicine & Child Neurology. 40(2). 126–129. 31 indexed citations
17.
Goldstein, Gérald, Ruth Condray, Carol J. Schramke, Robert Stowe, & Graham Ratcliff. (1998). Poststroke Depression and Anxiety: Different Assessment Methods Result in Variations in Incidence and Severity Estimates. Journal of Clinical and Experimental Neuropsychology. 20(5). 723–737. 46 indexed citations
18.
Putnam, Philip E., Susan R. Orenstein, Henry B. Wessel, & Robert Stowe. (1992). Tardive dyskinesia associated with use of metoclopramide in a child. The Journal of Pediatrics. 121(6). 983–985. 51 indexed citations
19.
Price, Bruce H., Kirk R. Daffner, Robert Stowe, & M.‐Marsel Mesulam. (1990). THE COMPORTMENTAL LEARNING DISABILITIES OF EARLY FRONTAL LOBE DAMAGE. Brain. 113(5). 1383–1393. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jon‐Kar Zubieta Breakdown of academic impact, for papers by Shenxun Shi Breakdown of academic impact, for papers by Eilis Boudreau Breakdown of academic impact, for papers by Jordi Gascón‐Bayarri Breakdown of academic impact, for papers by Rachel Galioto Breakdown of academic impact, for papers by Joana Fernandes Breakdown of academic impact, for papers by Guilherme Riccioppo Rodrigues Breakdown of academic impact, for papers by Maria Pąchalska Breakdown of academic impact, for papers by Pei‐Shen Ho Breakdown of academic impact, for papers by Ching‐Jui Chang
Rankless by CCL
2026